Lanean...

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies

There have been promising results from clinical trials on the efficacy of engineering patients’ immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Adv Pract Oncol
Egile Nagusiak: Stadtmauer, Edward, Mangan, Patricia A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Harborside Press 2017
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6003752/
https://ncbi.nlm.nih.gov/pubmed/29928544
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!